Hinge Health Inc. (HNGE) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Hinge Health Inc. (HNGE) carries a Roarable Rating of C (Hold) with 64/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How HNGE Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $587.9M | 79.6% | -92.9% | -$528.3M | $170.7M | -45% |
| FY 2024 | $390.4M | 76.8% | -8.2% | -$11.9M | $48.0M | -45% |
| FY 2023 | $292.7M | 44% | -44.6% | -$108.1M | -$77.1M | -3.3% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring HNGE)
- ✓Live walkthrough of HNGE's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
HNGE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +50.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on HNGE today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for HNGE. Explore sector supply chains on /butterfly.
HNGE Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Hinge Health Inc. (HNGE)?
In FY 2025 (10-K), HNGE converted $587.9M of revenue into a 79.6% gross margin, 0% operating margin, and $170.7M in free cash flow (29% FCF margin).